As of Nov 21
| -0.02 / -0.83%|
The 2 analysts offering 12-month price forecasts for Anavex Life Sciences Corp have a median target of 13.00, with a high estimate of 16.00 and a low estimate of 10.00. The median estimate represents a +441.67% increase from the last price of 2.40.
The current consensus among 2 polled investment analysts is to Buy stock in Anavex Life Sciences Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.